This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Monash University, Purdue Research Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Mohammad Abul Kalam Azad: Innovator in Antimicrobial Inhalation Formulations
Introduction
Mohammad Abul Kalam Azad is a notable inventor based in Melton South, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of inhalation formulations for antimicrobial compounds. His innovative work aims to improve treatment options for lung infections.
Latest Patents
Azad holds a patent for "Inhalation formulations of antimicrobial compounds." This patent outlines a method for reducing the toxicity of inhaled polymyxins as a therapeutic agent. It includes the co-administration of an aminoglycoside to enhance safety and efficacy. Additionally, the patent describes a method for improving the aerosolization of aminoglycosides through combination formulations with polymyxins. The process for manufacturing a dry powder composition comprising both polymyxins and aminoglycosides is also detailed. This invention encompasses pharmaceutical compositions and methods of treatment specifically targeting lung infections. He has 1 patent to his name.
Career Highlights
Throughout his career, Azad has worked with reputable institutions such as Purdue Research Foundation and Monash University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Qi Zhou and Maizbha Uddin Ahmed. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Mohammad Abul Kalam Azad's contributions to antimicrobial inhalation formulations highlight his commitment to improving healthcare outcomes. His innovative approaches and collaborations continue to influence the field of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile